Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
mesenchymal stem cells (Aspire Health Science)
- Development stage
- Preclinical
- Lead developer
- Aspire Health Science
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intraarticular, Intranasal, Inhalation, Intrathecal, Intra-arterial, Intracoronary, Direct Intra-tissue
01
Overview
Mesenchymal stem cells (MSCs) derived from perinatal tissue are a cell therapy product under development by Aspire Health Science, a Contract Development and Manufacturing Organization (CDMO). These cells, typically harvested from tissues such as the umbilical cord or placenta, are multipotent stromal cells capable of differentiating into various cell lineages and possessing significant immunomodulatory and regenerative potential. Aspire Health Science is currently in the preclinical stage of process development for these cells, focusing on leveraging their ability to modulate inflammatory environments and promote tissue repair through the secretion of trophic factors and direct cellular interactions.
- Other names
- mesenchymal stromal cellsperinatal tissue-derived mesenchymal stem cellsperinatal MSCs
Beyond the preview
Go deeper on mesenchymal stem cells (Aspire Health Science).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on mesenchymal stem cells (Aspire Health Science).